Novel Quantitative PET Imaging Techniques in Tuberculosis - 05/03/20
Doi : 10.1016/j.cpet.2019.11.010
Viplav Deogaonkar, MBBS a, Bangkim Chandra Khangembam, MD, FANMB b, Siavash Mehdizadeh Seraj, MD a, Abass Alavi, MD a, Rakesh Kumar, MD, PhD c, ⁎ 
, Mboyo-di-tamba Vangu, MD, MMed d, Gregory Bisson, MD, MSCE e
, Mboyo-di-tamba Vangu, MD, MMed d, Gregory Bisson, MD, MSCE e a Department of Radiology, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA
b Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
c Diagnostic Nuclear Medicine Division, All India Institute of Medical Sciences, New Delhi 110029, India
d Department of Nuclear Medicine, University of Johannesburg, PO Box 524, Auckland Park 2006, South Africa
e Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104-602, USA
∗Corresponding author.
Résumé |
The role of fluorodeoxyglucose (FDG)-PET/computed tomography (CT) in tuberculosis (TB) continues to expand in disease detection, assessment of the extent of the disease, and treatment response monitoring. This article reviews available data regarding the use of FDG-PET/CT in patients with TB. A new method of quantification for patients with TB is introduced. This method produces robust parameters that represent the total disease burden.
Le texte complet de cet article est disponible en PDF.Keywords : Quantification, Tuberculosis, Global assessment, FDG, PET/CT
Plan
© 2019
Elsevier Inc. Tous droits réservés.
Vol 15 - N° 2
P. 231-240 - avril 2020 Retour au numéro
Article précédent
- Infection and Inflammation Imaging : Beyond FDG
- Malte Kircher, Constantin Lapa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?